Continuous glucose monitor for newly diagnosed type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests whether using a continuous glucose monitor (CGM) helps people who were just diagnosed with type 2 diabetes manage their blood sugar better. Participants wear a small sensor on their arm that checks sugar levels all the time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes in the last 4 weeks.
- Your most recent A1c blood test is between 7.5% and 9.9%.
- You are 18 years old or older.
- Your body mass index (BMI) is over 25.
- You are not pregnant or planning to become pregnant during the study.
- You do not need insulin now, and you have no severe health issues that would make the study unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if using a continuous glucose monitor (a small sensor that checks blood sugar without finger pricks) helps people with type 2 diabetes who are on insulin and have trouble accessing care. It's for patients in the New Orleans area with Medicaid, free care, or no insurance.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study compares wearing a continuous glucose monitor (CGM) all the time versus only now and then for people with type 2 diabetes who do not use insulin. It aims to see which way helps manage blood sugar better.
This trial tests if using a continuous glucose monitor (CGM) helps older adults with type 2 diabetes who are not on insulin to better control their blood sugar. The results will show if CGM is a helpful tool for managing diabetes without daily shots.
Hear when a new Diabetes Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.